These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9308722)

  • 1. Nuclear overexpression of p53 protein does not correlate with gene mutation in primary peritoneal carcinoma.
    Marchenko ND; Moll UM
    Hum Pathol; 1997 Sep; 28(9):1002-6. PubMed ID: 9308722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p53 alteration in primary peritoneal carcinoma.
    Moll UM; Valea F; Chumas J
    Int J Gynecol Pathol; 1997 Apr; 16(2):156-62. PubMed ID: 9100070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
    Soong R; Knowles S; Hammond IG; Michael C; Iacopetta BJ
    Cancer Detect Prev; 1999; 23(1):8-12. PubMed ID: 9892985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma.
    Kowalski LD; Kanbour AI; Price FV; Finkelstein SD; Christopherson WA; Seski JC; Naus GJ; Burnham JA; Kanbour-Shakir A; Edwards RP
    Cancer; 1997 Apr; 79(8):1587-94. PubMed ID: 9118043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors.
    Nishimura- M; Wakabayashi M; Hashimoto T; Shibata J; Ueyama H; Ebina M; Fujiyama Y; Bamba T
    J Gastroenterol; 2000; 35(7):540-7. PubMed ID: 10905363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression and genetic abnormality of p53 in parathyroid adenomas.
    Kishikawa S; Shan L; Ogihara K; Utsunomiya H; Nakamura M; Nakamura Y; Naito A; Kakudo K
    Pathol Int; 1999 Oct; 49(10):853-7. PubMed ID: 10571817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Luce MC; Takahashi H; Boyd J
    Gynecol Oncol; 1996 Mar; 60(3):339-44. PubMed ID: 8774636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
    Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
    Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.
    Gao JP; Uchida T; Wang C; Jiang SX; Matsumoto K; Satoh T; Minei S; Soh S; Kameya T; Baba S
    Int J Oncol; 2000 Mar; 16(3):469-75. PubMed ID: 10675477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of immunohistochemistry-laser microdissection-PCR technique in detecting p53 gene mutation in paraffin sections of gastric cancer].
    Xu JH; Chen LR; Wang HJ; Yao LF
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):342-5. PubMed ID: 15363320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
    Fan P; Wu Z; Cha X; Wang X; Wang S
    Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
    Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
    Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.